Tech Company Financing Transactions
Nocion Therapeutics Funding Round
Nocion Therapeutics, based in Waltham, secured $27 million from BioInnovation, Canaan Partners and F-Prime Capital.
Transaction Overview
Company Name
Announced On
4/19/2019
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
100 Beaver St. 308
Waltham, MA 02453
USA
Waltham, MA 02453
USA
Phone
Undisclosed
Website
Email Address
Overview
NOCION is a biopharmaceutical company that is addressing vexing medical problems head on. We are developing nocions--a new kind of therapy that selectively affects actively firing nocioceptors--to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Batycky
Chief Medical Officer
Christopher Silber
Chief Scientific Officer
James Ellis
Vice President
Bridget Cole
Vice President
Michael Lipp
VP - Bus. Development
Christopher Searcy
Browse more venture capital transactions:
Prev: 4/19/2019: Redox venture capital transaction
Next: 4/19/2019: NuvoAir venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs